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Considerable heterogeneity among training-induced effects is observed in patients with cystic
fibrosis (CF). We previously showed that longitudinal changes in exercise capacity in adoles-
cents with CF were negatively associated with Pseudomonas aeruginosa (P. aeruginosa) colo-
nization and total immunoglobulin G (IgG) levels, independent of age, pulmonary function and
bodyweight. This is the first study investigating whether chronic inflammation and infection
also associate with the exercise training response in adolescents with CF.
Participants performed a home-based exercise training program for 12 weeks. Pulmonary
function, anthropometrics, exercise capacity, markers of inflammation and P. aeruginosa colo-
nization status were measured at baseline. Exercise training-induced changes in pulmonary
function and exercise capacity were compared between patients with a low and high inflam-
mationeinfection status.edical Centre Utrecht, Wilhelmina Children’s Hospital, Department of Paediatric Respiratory Medi-
85090, 3508 AB Utrecht, The Netherlands. Tel.: þ31 88 755 4757; fax: þ31 88 755 4747.
@umcutrecht.nl (P.B. van de Weert-van Leeuwen).
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446 P.B. van de Weert-van Leeuwen et al.Participants with CF with high total IgG levels and P. aeruginosa colonization improved
significantly less from the exercise training program, with regard to maximal oxygen consump-
tion.
These observations support the hypothesis that chronic systemic inflammation and infection
leads to devastating effects on skeletal muscles, hampering skeletal muscle tissue to improve
from regular physical exercise. Data further suggest that patients with CF should preferentially
be encouraged to engage in regular physical exercise when inflammation and infection status is
low (e.g. at a young age).
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Patients with cystic fibrosis (CF) are encouraged to engage
in regular physical exercise, since CF is associated with a
reduced physical fitness and exercise capacity has been
identified as an independent predictor of morbidity and
mortality in these patients [1e4]. Regular physical exercise
has been shown to improve pulmonary function, exercise
capacity, muscle strength and quality of life in adults and
children with CF, however considerable heterogeneity
among training-induced effects is observed and, of which
the underlying mechanisms are unknown [5].
Exercise intolerance in patients with cystic fibrosis (CF) is
associated with a reduced pulmonary function [4,6e11],
nutritional status [4,6e9], daily physical activity levels
[12,13], chronic inflammation [4,14] and infection [4]. We
previously showed that the exercise capacity declines 20%
during adolescence in subjectswithCF, ofwhichPseudomonas
aeruginosa (P. aeruginosa) colonization status and total
immunoglobulin G (IgG) levels were important determinants,
independent of age, pulmonary function and bodyweight [4].
Enhanced circulating levels of pro-inflammatory media-
tors, such as TNF-a and interleukin (IL)-6, induce muscle
cachexia [15,16] and have been associated with a reduced
exercise capacity and skeletal muscle function in patients
with CF and chronic obstructive pulmonary disease (COPD)
[14,17]. Presence of such a catabolic state may affect the
exercise training response in patients with CF and therefore
be an explanation for the inconsistent results found by
previous exercise training studies.
P. aeruginosa colonization is associated with a decline in
pulmonary function [18], exercise capacity [4], increased
morbidity and mortality [19,20] and is a main contributor to
chronic inflammation in patients with CF [21]. However,
whether chronic P. aeruginosa infection also contributes to
differences in the exercise training response in patients
with CF has never been studied.
Therefore, the aim of this study was to evaluate whether
the exercise training response in adolescent with CF
differed between those with a low or high inflammation or
infection status.
Material and methods
Subjects
An open prospective intervention study involving adoles-
cent (12e18-years-old) patients with CF was performed.Included patients had homozygous F508del mutations and
were clinically stable, which meant no use of extra oral or
intravenous antibiotics for at least four weeks prior to
participation. Patients were excluded from participation
when they used (inhaled) corticosteroids and/or immuno-
suppressive therapy, when they had CF-related diabetes
mellitus and/or when they had undergone lung trans-
plantation. Of 208 patients from the paediatric department
of the CF-centre Utrecht (Netherlands), 60 patients were
eligible for inclusion and 17 patients volunteered to
participate. All participants, and if needed also their par-
ents, gave written informed consent. The study was
approved by the local medical ethics committee (UMC
Utrecht).Exercise training program
Participants executed a home-based exercise training
program for 12 weeks [22]. The exercise training program
was adjusted for children with CF by one of the exercise
physiologists of our CF-centre. Briefly, the program is
composed of six charts, which were arranged in increasing
order of difficulty. The intensity was graded progressively
by the patients based on their perceived exertion. Each
session consisted of five basic exercises that had to be
performed within 11 min for 5 days a week, without the
need for specialized equipment. The first four exercises are
callisthenic exercises (stretching, sit-ups, back extension,
push-ups) and the fifth is an aerobic exercise (running).
Individual starting levels of the exercise training program
were based on measurement of physical fitness scores at
the first visit. Patients were instructed how to perform the
exercises at the start of the study. Progression was evalu-
ated by telephone after three and nine weeks and a visit to
the outpatient clinic after six weeks. Repetitive in-
structions were given, if needed. Furthermore, a diary was
used by the participants to record exercise training pro-
gression. Detailed information of the study is visualized in
Fig. 1.Anthropometrics
Nutritional status was determined pre- and post-training by
measurement of bodyweight, height, and body mass index
(BMI), which were expressed as standard deviation score
(SDS) based on reference values for healthy Dutch adoles-
cents [23].
Figure 1 Study scheme. Definition of abbreviations: UMCUZ University Medical Centre Utrecht, CPETZ Cardiopulmonary ex-
ercise test.
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Pulmonary function was measured pre- and post-training
after inhalation of 800 mg salbutamol. From the best of
three maximal expiratory flow-volume curves (Master-
screen; Cardinal health, Houten, the Netherlands), the
forced expiratory volume in 1 s (FEV1; l) was obtained and
expressed as percent predicted (FEV1%pred) [24].
Daily physical activity levels
Daily physical activity levels were assessed pre-training
using the uniaxial ActiTrainer accelerometer (ActiGraph,
FL, USA). It measures step count and acceleration in a
single (vertical) axis, which were calculated by the ActiLife
software (version 3.6.0). Participants wore the acceler-
ometers for 3 consecutive days on the right hip from the
moment they woke up until bed time. Data were expressed
as step counts and activity counts per day.
Cardiopulmonary exercise test
The maximal exercise capacity of the participants was
measured pre- and post-training by a cardiopulmonary exer-
cise test (CPET) according to the Godfrey protocol [25] as has
previously been described [4]. Effort was consideredmaximal
when one of the following criteria was met: 1. heart rate
(HRpeak)> 180beats perminute, 2. respiratory exchange ratio
(RERpeak)> 1.00 [26]. Maximal exercise capacity was calcu-
latedas theaverage valueover the last 30 s of the test andwas
expressed as VO2peak (l min
1) and VO2peak corrected for
bodyweight (VO2peak/kg; l kg
1 min1). Maximal exercise
valueswere expressed as absolute values (VO2peak, VO2peak/kg)
and percent predicted (VO2peak%pred, VO2peak/kg%pred) by
using reference values of Dutch healthy adolescents [27],
which allowed to adjust for age, gender and weight.
P. aeruginosa infection status
Sputum cultures, which were available from all regular
visits during the entire year preceding the first visit of this
study, were evaluated. According to the Leeds criteria,
participants were classified as colonized with P. aeruginosawhen 50% of the sputa or cough swab cultures were pos-
itive for P. aeruginosa in the preceding year [28].
Inflammatory markers
C-reactive protein (CRP), total IgG and leukocyte levels
were measured in peripheral blood prior to the start of the
CPET, pre- and post-training. Inflammatory markers were
chosen based on previous data showing significant correla-
tions between these specific inflammatory markers and
pulmonary function or exercise capacity [4,17,29,30].
Statistical analysis
A KolmogoroveSmirnov test was used to test whether the
variables were normally distributed. Patient characteristics
were expressed as means and standard deviations (SD)
when variables were normally distributed, otherwise as
median and interquartile range (IR). Categorical data were
expressed as percentage frequency.
To investigate whether inflammation or infection status
was associated with the exercise training response in patients
with CF, participants were stratified in different groups. Since
we previously observed a negative association between total
IgG levels, P. aeruginosa colonization status and longitudinal
changes in exercise capacity in adolescents with CF [4], we
chose these parameters as markers for infection and inflam-
mation status. Total IgG levels were considered high when
levels were 10.5 g l1. This threshold was chosen based on
normal levels for adolescents, which range between 5.2 and
15.6 g l1. Infection status was considered highwhen patients
were colonized with P. aeruginosa. “Inflammationeinfection
status”, in which both markers were combined, was consid-
ered high only when patients were colonized with P. aerugi-
nosa and total IgG levels exceeded the threshold of 10.5 g l1.
All data were analyzed in SPSS 20.0 for Windows (SPSS Inc,
Chicago, Ill, USA). A p-value of <0.05 was considered to be
statistically significant.
Results
Seventeen adolescent patients with CF volunteered to
participate and 13 patients completed the training.
Patients prematurely dropped out of the study for several
448 P.B. van de Weert-van Leeuwen et al.reasons. One patient had attention deficit hyperactivity
disorder (ADHD) in combination with an autistic disorder,
which made it too difficult to be compliant to the pre-
scribed exercise training program. The other three patients
dropped out, since it was not possible for them to imple-
ment the exercise training program in their daily activities.
The data of the remaining 13 patients were analyzed.
Patients were stratified according to their inflammation and
infection status. Table 1 summarizes the baseline charac-
teristics of the patients at the first visit categorized for the
different stratification categories (total IgG inflammation
status, P. aeruginosa infection status, inflamma-
tioneinfection status). No baseline differences were found
when patients were stratified according to their total IgG
level status. Participants with 50% positive P. aeruginosa
cultures were significantly older and had a better nutri-
tional status indicated by a significantly higher SDS weight
and SDS height. A significant difference in SDS weight was
also observed when patients were stratified according to
the inflammationeinfection status (Table 1). At the end of
the study period SDS scores for BMI were unchanged
compared to baseline values for all sub-groups: inflamma-
tion status low (pZ 0.12), inflammation status high
(pZ 0.30), infection status low (pZ 0.78), infection status
high (pZ 0.08), inflammationeinfection status low
(pZ 0.13) and inflammationeinfection status high
(pZ 0.35).
No significant differences between high and low
inflammationeinfection status were observed with regard
to exercise training adherence (Table 2).
No significant differences in training response were
observed when patients were stratified according to total
IgG levels or P. aeruginosa infection status, except for less
lung function improvement in patients with P. aeruginosa
colonization. However a trend was observed, toward a
better training response in patients with CF with a low
inflammation or infection status. When participants were
stratified based on their inflammationeinfection status,
participants with a low inflammationeinfection status
improved significantly more, with regard to exercise ca-
pacity, from the exercise training program, compared to
patients with CF with a high inflammationeinfection status
at the start of the study (Fig. 2 and Table 3).Discussion
The aim of this study was to investigate whether the ex-
ercise training response in adolescents with CF was asso-
ciated with their inflammation and infection status. This
study showed that the exercise training response in ado-
lescents with CF was less when inflammation and infection
status was high, even when training responses were cor-
rected for differences in age and weight by using reference
values.
Present data showed that colonization with P. aeruginosa
and total IgG levels not only negatively associated with ex-
ercise capacity as we have previously shown [4], but also the
exercise training response in adolescents with CF. How
chronic inflammation and infection exactly lead to a reduced
exercise training response, is unknown. The hypothesis that
chronic systemic inflammation leads to a catabolic stateaffecting skeletal muscle dysfunction, may also hamper pa-
tients to improve from regular physical exercise [15,16]. It
has already been shown in 90-years-old female nursing home
residents that enhanced circulating levels of TNF-a receptor
p55, a pro-inflammatory marker, were associated with a
lower exercise training response [31].
P. aeruginosa is an important contributor to chronic
inflammation [32,33]. A pulmonary infection with P. aeru-
ginosa in a mouse model weakened the diaphragm, inde-
pendently of pulmonary inflammation [34]. Colonization
with P. aeruginosa may therefore also lead to a catabolic
state, hampering the exercise training response in these
patients.
Additionally, a single exercise session in healthy people
has been shown to lead to immune activation. This is
characterized by a leukocytosis with leukocytes displaying
an activated phenotype and enhanced circulating levels of
cytokines and chemokines, such as IL-6 and TNF-a [35]. A
single exercise session in patients with CF also leads to a
leukocytosis comparable to what was observed in age-
matched controls [36,37], however higher increases of
pro-inflammatory markers, such as TNF-a [38], TNF-a sol-
uble receptor I [39], IL-6 [38,39], and IL-6 soluble receptor
[39] were observed, which also remained higher for a longer
period [38,39]. These data may suggest that repetitive
single exercise sessions in patients with CF may lead to
recruitment of leukocytes which produce higher amounts of
pro-inflammatory cytokines, therefore leading to devas-
tating effects on skeletal muscle tissue, instead of im-
provements of skeletal muscle function. For this study, we
choose not to measure cytokine levels, since cytokine
measurements in a small group of patients would lead to
highly variable results [40]. However, for future studies
cytokine analysis should be performed, at least or IL-6 and
TNF-a.
We used P. aeruginosa colonization status and IgG levels
as markers for inflammation and infection, which are both
good representatives of the chronic inflammation and
infection status in patients with CF in general. IgG pro-
duction increases upon a pulmonary infection with P. aer-
uginosa and may already be present before the first positive
culture [41e43]. IgGs facilitate clearance of P. aeruginosa
by opsonizing them [44]. Additionally, patients colonized
with P. aeruginosa show chronically elevated IgG levels
[45]. Additionally, IgGs lead to cytokine production upon
activation of Fc receptors [46,47], suggesting that it is a
good marker for inflammation as well. Compared to cyto-
kines, the half-life of IgGs is much greater. IgG levels are
therefore more steadily present and less influenced by
circumstantial factors (e.g. heat, exercise, pulmonary ex-
acerbations) than cytokines. IgG levels in combination with
P. aeruginosa colonization status are therefore good
markers of both inflammation and infection status.
Chronic inflammation and infection may lead to
increased rates of intravenous treatment and hospitaliza-
tion, which invalidate patients and lead to a reduction in
habitual physical activity levels, which might therefore
lead to a difference in training response. However, daily
physical activity levels were not different at the start of the
study. Although patients with a high inflamma-
tioneinfection status trained less (32.0 days) compared to
patients with a low inflammationeinfection load (41.5
Table 1 Baseline characteristics at first visit.
IgG levels at
first visit <
10.5 g l1
IgG levels at first
visit 10.5 g l1
p-value Cultures positive for
P. aeruginosa <50%
Cultures positive for
P. aeruginosa 50%
p-value Low inflammatione
infection status
High inflammatione
infection status
p-value
Patients (n) 4 9 4 9 10 3
Age (years)* 14.60 (0.95) 14.81 (2.00) 0.85 12.94 (0.65) 15.56 (1.36) 0.004 14.29 (1.55) 16.28 (1.46) 0.08
Physical activity
level (step
count/day)*
8386.22
(2508.03)
6838.94 (2192.65) 0.35 7271.06 (2703.31) 7324.50 (2214.67) 0.97 7597.36 (2327.58) 6126.17 (2251.19) 0.45
Anthropometrics
Weight
(SDS for age)*
0.44 (0.51) 0.57 (0.73) 0.75 1.16 (0.70) 0.25 (0.39) 0.01 0.68 (0.67) 0.03 (0.14) 0.02
Height
(SDS for age)*
0.29 (0.89) 0.27 (1.02) 0.97 1.07 (0.93) 0.08 (0.75) 0.04 0.42 (1.00) 0.20 (0.64) 0.34
BMI (SDS for age)* 0.23 (0.21) 0.64 (0.59) 0.21 0.81 (0.54) 0.38 (0.51) 0.19 -0.58 (0.55) 0.32 (0.53) 0.49
Exercise capacity
VO2peak/kg
(ml min1 kg1)*
41.13 (6.60) 36.06 (8.21) 0.30 35.96 (6.91) 38.36 (8.53) 0.63 36.92 (7.10) 39.97 (11.51) 0.58
VO2peak%pred
(% predicted)*
83.76 (13.19) 79.15 (19.14) 0.67 78.06 (6.17) 81.69 (20.50) 0.64 78.79 (14.18) 86.49 (27.98) 0.52
VO2peak/kg%pred
(% predicted)*
88.36 (9.15) 85.61 (21.41) 0.38 93.30 (18.43) 83.41 (18.20) 0.72 86.54 (16.89) 86.17 (26.19) 0.98
Lung function
FEV1%pred
(% predicted)*
96.00 (19.95) 75.32 (25.31) 0.18 74.73 (23.68) 84.78 (26.31) 0.53 78.59 (25.47) 92.00 (25.00) 0.44
Inflammation and
infection status
CRP level (mg l1)y 0.00
(0.00e3.00)
0.00 (0.00e9.00) 0.50 0.00 (0.00e2.00) 0.00 (0.00e9.00) 0.41 0.00 (0.00e6.00) 0.00
(0.00e26.00)
1.00
Leukocyte level
(109 l1)y
7.00
(5.80e7.80)
6.80 (5.90e8.40) 1.00 6.25 (5.25e6.90) 7.80 (6.20e11.60) 0.20 6.90 (5.70e11.60) 6.50
(5.90e8.40)
0.94
Cultures positive
for P. aeruginosa
(%)*
68.13 (21.93) 47.37 (38.54) 0.34
IgG total level
(g l1)y
13.90 (12.45e15.80 12.30
(10.00e15.20)
0.60 12.45 (10.00e15.10) 15.20
(12.50e16.70)
0.29
Data are presented as: *mean (SD) or
y
median (IR). Definition of abbreviations: nZ Number, VO2peak/kgZ Peak oxygen consumption per kg bodyweight, VO2peak%predZ Peak oxygen
consumption percent predicted, VO2peak/kg%predZ Peak oxygen consumption per kg bodyweight percent predicted, FEV1%predZ Forced expiratory volume in 1 s percent predicted,
CRPZ C-reactive protein, IgGZ Immunoglobulin G. Inflammationeinfection status was defined as high when both IgG levels and P. aeruginosa positive cultures exceeded the threshold of
10.5 g l1 and 50%, respectively.
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Figure 2 Difference in DVO2peak/kg%pred between partici-
pants with a low or high inflammationeinfection status. Data
are presented as mean (SD). Definition of abbreviations:
DZ Absolute difference in exercise capacity post-versus pre-
training, VO2peak/kg%predZ Peak oxygen consumption per kg
bodyweight percent predicted. Inflammationeinfection status
was defined as high when both IgG levels and P. aeruginosa
positive cultures exceeded the threshold of 10.5 g l1 and 50%,
respectively.
450 P.B. van de Weert-van Leeuwen et al.days), this was not significantly different. Furthermore, the
use of extra antibiotics besides regular antibiotic treatment
and the hospital admission rate were not statistically
different between both groups (data not shown).
The sample size of this study is too small to draw definite
conclusions on the relationship between infec-
tioneinflammation status and exercise training responses.
However, the observed negative association in our patients
deserves further studies into the role of lung function
impairment and inflammatory lung destruction in patients
who start training programmes.
Although data are based on a small sample size and
patients were not randomized for the exercise training
program, this is the first study showing that the exercise
training response is negatively associated with inflamma-
tion and infection status in adolescents with CF. Data may
suggest that adolescents with CF should preferentially be
encouraged to engage in regular physical exercise when
inflammation and infection status is low (e.g. at a young
age), since patients probably will benefit more from regular
physical exercise.Funding
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